Gender |
|
|
Male |
60.0% |
12/20 |
Female |
40.0% |
8/20 |
Indifferent |
0% |
0/20 |
Unknown |
0% |
0/20 |
Neurology |
|
|
Neurological abnormalities |
88.2% |
15/17 |
Generalized hypotonia |
47.1% |
8/17 |
Ataxia |
23.5% |
4/17 |
Absence seizures |
11.8% |
2/17 |
EEG abnormality |
11.8% |
2/17 |
Seizures |
11.8% |
2/17 |
Absent speech |
5.9% |
1/17 |
Central hypotonia |
5.9% |
1/17 |
Delayed speech and language development |
5.9% |
1/17 |
Epileptic spasms |
5.9% |
1/17 |
Generalized tonic seizures |
5.9% |
1/17 |
Generalized seizures |
5.9% |
1/17 |
Global developmental delay |
5.9% |
1/17 |
Hearing impairment |
5.9% |
1/17 |
Horizontal nystagmus |
5.9% |
1/17 |
Intellectual disability |
5.9% |
1/17 |
Intellectual disability, moderate |
5.9% |
1/17 |
Oromotor apraxia |
5.9% |
1/17 |
Spastic gait |
5.9% |
1/17 |
Specific learning disability |
5.9% |
1/17 |
Visual impairment |
5.9% |
1/17 |
Behavioral problems |
55.0% |
11/20 |
Attention deficit hyperactivity disorder |
20.0% |
4/20 |
Behavioral abnormality |
15.0% |
3/20 |
Autism |
10.0% |
2/20 |
Fatigue |
10.0% |
2/20 |
Self-injurious behavior |
10.0% |
2/20 |
Sleep disturbance |
10.0% |
2/20 |
Abnormal social behavior |
5.0% |
1/20 |
Aggressive behavior |
5.0% |
1/20 |
Anxiety |
5.0% |
1/20 |
Autistic behavior |
5.0% |
1/20 |
Depression |
5.0% |
1/20 |
Difficulty walking |
5.0% |
1/20 |
Impaired social interactions |
5.0% |
1/20 |
Restrictive behavior |
5.0% |
1/20 |
Sleep apnea |
5.0% |
1/20 |
Brain abnormality |
75.0% |
12/16 |
Hypoplasia of the corpus callosum |
37.5% |
6/16 |
Abnormality of the cerebral ventricles |
6.3% |
1/16 |
Abnormality of the periventricular white matter |
6.3% |
1/16 |
Aplasia/Hypoplasia of the cerebral white matter |
6.3% |
1/16 |
Arachnoid cyst |
6.3% |
1/16 |
Asymmetric ventricles |
6.3% |
1/16 |
Brain abscess |
6.3% |
1/16 |
Brainstem dysplasia |
6.3% |
1/16 |
Cavum septum pellucidum |
6.3% |
1/16 |
Cerebellar atrophy |
6.3% |
1/16 |
Cerebellar hypoplasia |
6.3% |
1/16 |
Cortical dysplasia |
6.3% |
1/16 |
Diffuse cerebral atrophy |
6.3% |
1/16 |
Dilation of lateral ventricles |
6.3% |
1/16 |
EEG abnormality |
6.3% |
1/16 |
Frontal cortical atrophy |
6.3% |
1/16 |
Global brain atrophy |
6.3% |
1/16 |
Microcephaly |
6.3% |
1/16 |
Perivascular spaces |
6.3% |
1/16 |
Periventricular leukomalacia |
6.3% |
1/16 |
Periventricular cysts |
6.3% |
1/16 |
Facial abnormalities |
|
|
Abnormality of the ear |
20.0% |
2/10 |
Abnormality of the outer ear |
10.0% |
1/10 |
Abnormality of the eye |
33.3% |
3/9 |
Hypermetropia |
11.1% |
1/9 |
Hypotelorism |
11.1% |
1/9 |
Long palpebral fissure |
11.1% |
1/9 |
Thick eyebrow |
11.1% |
1/9 |
Abnormality of the nose |
22.2% |
2/9 |
Anteverted nares |
11.1% |
1/9 |
Broad nasal tip |
11.1% |
1/9 |
Wide nasal ridge |
11.1% |
1/9 |
Abnormality of the mouth |
40.0% |
4/10 |
Gingival overgrowth |
10.0% |
1/10 |
High palate |
10.0% |
1/10 |
Narrow palate |
10.0% |
1/10 |
Open mouth |
10.0% |
1/10 |
Oromotor apraxia |
10.0% |
1/10 |
Smooth philtrum |
10.0% |
1/10 |
Thick lower lip vermilion |
10.0% |
1/10 |
Thin upper lip vermilion |
10.0% |
1/10 |
Visual and hearing impairments |
|
|
Abnormal hearing |
21.1% |
4/19 |
Hearing impairment |
15.8% |
3/19 |
Mild hearing impairment |
5.3% |
1/19 |
Abnormal vision |
52.6% |
10/19 |
Strabismus |
21.1% |
4/19 |
Abnormality of refraction |
10.5% |
2/19 |
Abnormality of the optic nerve |
5.3% |
1/19 |
Abnormality of vision |
5.3% |
1/19 |
Astigmatism |
5.3% |
1/19 |
Cortical visual impairment |
5.3% |
1/19 |
Hypermetropia |
5.3% |
1/19 |
Myopia |
5.3% |
1/19 |
Nystagmus |
5.3% |
1/19 |
Poor eye contact |
5.3% |
1/19 |
Heart |
|
|
Abnormality of the heart |
7.7% |
1/13 |
Bicuspid aortic valve |
7.7% |
1/13 |
Gastrointestinal |
|
|
Gastrointestinal abnormalities |
40.0% |
8/20 |
Constipation |
10.0% |
2/20 |
Feeding difficulties |
10.0% |
2/20 |
Gastroesophageal reflux |
10.0% |
2/20 |
Drooling |
5.0% |
1/20 |
Feeding difficulties in infancy |
5.0% |
1/20 |
Gastrointestinal dysmotility |
5.0% |
1/20 |
Ileal atresia |
5.0% |
1/20 |
Intestinal malrotation |
5.0% |
1/20 |
Malnutrition |
5.0% |
1/20 |
Ulcerative colitis |
5.0% |
1/20 |
Urogenital |
|
|
Abnormality of the urogenital system |
18.8% |
3/16 |
Cryptorchidism |
6.3% |
1/16 |
Menorrhagia |
6.3% |
1/16 |
Nocturia |
6.3% |
1/16 |
Shawl scrotum |
6.3% |
1/16 |
Skeleton |
|
|
Skeletal abnormalities |
50.0% |
9/18 |
Pes planus |
16.7% |
3/18 |
Broad hallux |
11.1% |
2/18 |
Joint laxity |
11.1% |
2/18 |
Prominent fingertip pads |
11.1% |
2/18 |
Scoliosis |
11.1% |
2/18 |
Abnormality of the knees |
5.6% |
1/18 |
Bifid ribs |
5.6% |
1/18 |
Broad thumb |
5.6% |
1/18 |
Hallux valgus |
5.6% |
1/18 |
Hip dysplasia |
5.6% |
1/18 |
Limitation of joint mobility |
5.6% |
1/18 |
Long palm |
5.6% |
1/18 |
Narrow palm |
5.6% |
1/18 |
Overlapping toe |
5.6% |
1/18 |
Positional foot deformity |
5.6% |
1/18 |
Tapered finger |
5.6% |
1/18 |
Toe syndactyly |
5.6% |
1/18 |
3-4 finger syndactyly |
5.6% |
1/18 |
Skin / Hair / Nails |
|
|
Abnormality of the skin/hair/nails |
20.0% |
3/15 |
Facial erythema |
6.7% |
1/15 |
Irregular hyperpigmentation |
6.7% |
1/15 |
Short nail |
6.7% |
1/15 |
Endocrine / Immunological / Metabolic |
|
|
Abnormality of the metabolic system |
10.0% |
1/10 |
Hyperprolinemia |
10.0% |
1/10 |
Abnormality of the immune system |
25.0% |
3/12 |
Asthma |
8.3% |
1/12 |
Recurrent infections |
8.3% |
1/12 |
Recurrent otitis media |
8.3% |
1/12 |